阿扎胞苷治疗骨髓增生异常综合征和急性髓系白血病的研究进展(4)
[7] Pleyer L， D？hner H， Dombret H， et al. Azacitidine for frontline therapy of patients with AML： reproducible efficacy established by direct comparison of international phase 3 trial data with registry data from the Austrian Azacitidine Registry of the AGMT study group [J/OL]. Int J Mol Sci ......
您现在查看是摘要页，全文长 2540 字符。